Surgical therapy of fulminant pulmonary embolism: Early and late results

Thoracic and Cardiovascular Surgeon

Volumn 47, Issue 1, 1999, Pages 9-13

  Doerge, H ^a   Schoendube, Friedrich A ^a   Voss M ^a   Seipelt, R ^a   Messmer, B J ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Cardiopulmonary resuscitation; Heparin induced thrombocytopenia; Pulmonary embolectomy; Pulmonary embolism; Vena caval filter

Indexed keywords

HEPARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOT LYSIS; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; EMBOLECTOMY; FEMALE; FOLLOW UP; HUMAN; LUNG EMBOLISM; MALE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; TREATMENT CONTRAINDICATION;

EID: 0032952944     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1013100     Document Type: Article

References (20)

1. Cooley DA, Beall AC, Alexander JK. Acute massive pulmonary embolism: surgical treatment using temporary cardiopulmory bypass. JAMA. 1961;177:283-6.
2. Bauer EP, Laske A, Segesser LK von, Carrel T, Turina M. Early and late results after surgery for massive pulmonary embolism. Thorac Cardiovasc Surg. 1991;39:353-6.
3. Clarke DB, Abrams LD. Pulmonary embolectomy: a 24-year experience. J Thorac Cardiovasc Surg. 1986;92:442-5.
4. Doerge HC, Schoendube FA, Loeser H, Walter M, Messmer BJ. Pulmonary embolectomy: review of a 15-year experience and role in the age of thrombolytic therapy. Eur J Cardiothorac Surg. 1996;10:952-7.
5. Gray HH, Miller GAH, Paneth M. Pulmonary embolectomy: Its place in the management of pulmonary embolism. Lancet. 1988;1:1441-5.
6. Jakob H, Vahl C, Lange R, Micek M, Tanzeem A, Hagl S. Modified surgical concept for fulminant pulmonary embolism. Eur J Cardio-thorac Surg. 1995;9:557-61.
7. Kieny R, Charpentier A, Kieny MT. What is the place of pulmonary embolectomy today? J Cardiovasc Surg. 1991; 32:549-54.
8. Meyer G, Tamisier D, Sors H, et al. Pulmonary embolectomy: a 20-year experience at one center. Ann Thorac Surg. 1991; 51:232-6.
9. Schmid C, Zietlow ST, Wagner FO, Laas J, Borst H. Fulminant pulmonary embolism: Symptoms, diagnostics, operative technique, and results. Ann Thorac Surg. 1991;52:1102-7.
10. Stulz S, Schläpfer R, Feer R, Habicht J, Grädel E. Decision making in the surgical treatment of massive pulmonary embolism. J Cardiothorac Surg. 1994;8:188-93.
11. Goldhaber SZ. Contemporary pulmonary embolism thrombolysis. Chest. 1995: 107 (Suppl.): S45-51.
12. Goldhaber SZ, Kessler CM, Heit J, et al. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet. 1988;2:293-8.
13. Verstraete M, Miller GAH, Bounameaux H, et al. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation. 1988;77:353-60.
14. Gulba DC, Dechend R. Thrombolysis in thromboembolic diseases. Ann Hematol. 1995; 69 (Suppl II): 41-57.
15. Simoons ML, Maggioni AP, Knatterud G, et al. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet. 1993;342:1523-8.
16. Kelton JG. Heparin-induced thrombocytopenia. Haemostasis. 1986;16(2):173-86.
17. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis. 1975;17:259-70.
18. Habicht JM, Hämmerli R, Perruchoud A, Müller J, Stulz P. Long-term follow-up in pulmonary embolectomy: is NYHA (dyspnea) classification reliable? Eur J Cardio-thorac Surg. 1996;10:32-7.
19. Walenga JM, Bakhos M, Messmore HL, Fareed J, Pifarre R. Potential use of recombinant hirudin as an anticoagulant in a cardiopulmonary bypass model. Ann Thorac Surg. 1991; 51:271-7.
20. Potzsch B, Madlener K, Seelig C, Riess CF, Greinacher A, Mueller-Berghaus G. Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass - assessment of the whole blood ecarin clotting time. Thromb Haemost. 1997;77:920-5.